NCT03323346 2025-07-20
DISC
The Institute of Molecular and Translational Medicine, Czech Republic
Phase 2 Recruiting
Clinical Trials
7 trialsNCT01777919 2025-05-25
GLIODIS
Olympion Medical Center
Phase 2 Not yet recruiting
NCT02715609 2025-04-10
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Washington University School of Medicine
Phase 1/2 Completed
NCT05709171 2023-11-22
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
Phase 2 Unknown
NCT04265274 2023-10-06
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
National Cancer Institute, Slovakia
Phase 2 Withdrawn
NCT02963051 2021-09-16
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer
Duke University
Phase 1 Terminated
NCT02678975 2021-03-18
Disulfiram in Recurrent Glioblastoma
Sahlgrenska University Hospital
Phase 2/3 Completed